To include your compound in the COVID-19 Resource Center, submit it here.

HspE7 (SGN-00101): Began Phase III trial

StressGen Biotechnologies Corp. (TSE:SSB), Victoria, B.C.
Product: HspE7

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE